KMTS
NASDAQKestra Medical Technologies Ltd.
Price$19.45-0.78 (-3.86%)
01:45 PM07:45 PM
News · 26 weeks29+200%
2025-12-142026-06-07
Mix1890d
- Insider9(50%)
- Other4(22%)
- SEC Filings3(17%)
- Offering2(11%)
Latest news
25 items- INSIDERChief Business Officer Moran Timothy P. was granted 22,704 shares, increasing direct ownership by 116% to 42,261 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDERChief Commercial Officer Ford Alfred J Jr was granted 25,227 shares, increasing direct ownership by 51% to 74,639 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDERChief Financial Officer Mahboob Vaseem was granted 25,227 shares, increasing direct ownership by 59% to 67,961 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDEROfficer Umberger Traci S was granted 25,227 shares, increasing direct ownership by 18% to 161,860 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDEROfficer Webster Brian Daniel was granted 75,681 shares, increasing direct ownership by 23% to 410,467 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDEROfficer Webster Brian Daniel sold $314,329 worth of shares (15,000 units at $20.96) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 334,786 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- PRKestra Medical Technologies to Present at the BofA Securities 2026 Healthcare ConferenceKIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, is scheduled to present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13 at 2:20 p.m. Pacific Time. Interested parties may access the live webcast and a replay of the presentation by visiting the Kestra investor relations website. About Kestra Medical TechnologiesKestra Medical Technologies is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, i
- PRKestra Showcases Accelerated Innovation at HRS 2026KIRKLAND, Wash., April 22, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, today announced it will exhibit at Heart Rhythm 2026, the annual meeting of the Heart Rhythm Society (HRS) taking place April 23–26 in Chicago. The company will showcase its Cardiac Recovery System® platform—a modern, integrated approach to managing sudden cardiac arrest (SCA) risk that unites proven therapy, actionable clinical insights, and ongoing patient support to enhance protection and optimize care. Kestra, one of the fastest-growing companies in medical technology, continues to build momentum as clinicians increasing
- INSIDERSEC Form 4 filed by Webster Brian Daniel4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- PRKestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award WinnerKIRKLAND, Wash., April 09, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a 2026 USA TODAY Top Workplaces award winner. "Being named a USA TODAY Top Workplace highlights a team dedicated to a meaningful purpose and mission with a commitment to making a real difference for patients and clinicians," said Brian Webster, President and CEO of Kestra Medical Technologies. "The opportunity to collaborate with people who share that responsibility creates strong alignment, defines our culture, and empowers our teams to work together to develop innovative, life-saving techn
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Kestra Medical Technologies Ltd.SCHEDULE 13G/A - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Subject)
- SECSEC Form S-3ASR filed by Kestra Medical Technologies Ltd.S-3ASR - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Filer)
- INSIDERSEC Form 4 filed by Cohen Raymond W4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- PRKestra Medical Technologies Named Finalist for 2026 GeekWire "Deal of the Year"KIRKLAND, Wash., March 25, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a finalist in the "Deal of the Year" category for the 2026 GeekWire Awards. Now in its 15th year, the annual awards recognize companies and leaders shaping the Pacific Northwest technology ecosystem, where Kestra continues to expand its presence. The "Deal of the Year" category recognizes impactful transactions including acquisitions, financings, and public offerings. Kestra was named a finalist for its successful 2025 initial public offering, a milestone that supports continued commercial e
- INSIDERSEC Form 4 filed by Webster Brian Daniel4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- SECSEC Form 10-Q filed by Kestra Medical Technologies Ltd.10-Q - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Filer)
- SECKestra Medical Technologies Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Filer)
- PRKestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial ResultsKIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the third quarter fiscal 2026, which ended January 31, 2026. Financial Highlights Generated revenue of $24.6 million in Q3 FY26, an increase of 63% compared to the prior year period.Expanded gross margin to 52.6% in Q3 FY26 compared to 43.4% in the prior year period.Increased FY26 revenue guidance to $93 million, representing growth of 55% compared to FY25. "Kestra delivered another strong quarter of financial performance, generating revenue growth of 63% while expanding gross margin to
- INSIDERDirector Reilly Kevin C was granted 8,300 shares (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- PRKestra Medical Technologies to Report Third Quarter Fiscal 2026 Financial Results on March 17KIRKLAND, Wash., March 03, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, today announced that it will report third quarter fiscal 2026 financial results on Tuesday, March 17. Management will host a corresponding conference call at 4:30 p.m. Eastern Time. A live and archived webcast of the conference call will be available in the "Events" section of the investor relations website. Participants are encouraged to register on the website 10 minutes prior to the start of the conference call. About KestraKestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare comp
- INSIDEROfficer Webster Brian Daniel sold $384,020 worth of shares (15,000 units at $25.60), decreasing direct ownership by 4% to 379,786 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Kestra Medical Technologies Ltd.SCHEDULE 13G/A - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Kestra Medical Technologies Ltd.SCHEDULE 13G/A - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Subject)
- SECSEC Form SCHEDULE 13G filed by Kestra Medical Technologies Ltd.SCHEDULE 13G - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Subject)
- INSIDEROfficer Webster Brian Daniel sold $342,024 worth of shares (15,000 units at $22.80), decreasing direct ownership by 4% to 394,786 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
KMTS FAQ
6 questionsWhere does KMTS stock trade?
Kestra Medical Technologies Ltd. (KMTS) is listed on NASDAQ.What sector and industry is KMTS in?
Kestra Medical Technologies Ltd. operates in the Health Care sector, Medical/Dental Instruments industry.When did Kestra Medical Technologies Ltd. go public?
Kestra Medical Technologies Ltd. (KMTS) completed its IPO in 2025.What are analysts saying about KMTS?
Kestra Medical Technologies Ltd. has had 7 recent analyst actions on file. The most recent action was from BTIG Research: Buy with a $3200.00 price target on 2025-11-18. Recent price targets range from $2400.00 to $3200.00.What companies are similar to KMTS?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare KMTS side-by-side with any of them on Quantisnow.How can I track KMTS on Quantisnow?
Quantisnow aggregates Kestra Medical Technologies Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KMTS to receive live email and push alerts on every new disclosure.